• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: SORIN GROUP ITALIA S.R.L PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

SORIN GROUP ITALIA S.R.L PERCEVAL SUTURELESS AORTIC HEART VALVE; TISSUE HEART VALVE Back to Search Results
Model Number PVS23
Device Problems Leak/Splash (1354); Incomplete Coaptation (2507); Folded (2630)
Patient Problem Aortic Insufficiency (1715)
Event Date 01/23/2017
Event Type  Injury  
Event Description
The patient underwent implantation of a size medium perceval valve for aortic valve replacement through an upper partial sternotomy.After implantation it was noticed that the non-coronary leaflet had a small folding on the leaflet.The patient went off bypass and on transesophageal echocardiogram, they could see a small intervalvular insufficiency.They decided to leave the valve implanted as they believed the central leakage would go back to normal after the valve had had time to adapt.After three days an echo showed an increase in the insufficiency and the patient had clear symptoms of dyspnea and an increase in pro-bnp.The surgeon decided to re-operate and during the reoperation they would see that the non-coronary leaflet did not work at all.It was stiff and not coapting with the other leaflets.The valve was replaced with another perceval valve of the same size after new measurements were taken.The new valve was working perfectly and the rest of the hospital stay was uneventful.
 
Manufacturer Narrative
Device received for analysis on (b)(6) 2017.Gross exam was completed (b)(6) 2017.
 
Event Description
Additional information was received on (b)(6) 2017 that the guiding sutures on the device were in fact removed from the device.
 
Manufacturer Narrative
The complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.The transthoracic echocardiogram from (b)(6) 2017 was received and reviewed by external consultants.The study is of very limited quality (poor images and limited views).Mean and peak gradients seem to be unremarkable (8/12 mmhg).Doppler velocity index is normal at 0.5.There is mild aortic regurgitation, cannot determine if central or paravalvular, nor the underlying mechanism.The visual inspection performed on the returned prosthesis confirmed the absence of manufacturing defects.The hydrodynamic testing conducted on the returned prosthesis confirmed that the device was showing normal leaflet kinematics with regurgitation fraction in compliance with requirement of en iso 5840:2015.Based on the performed analysis, the reported event cannot be explained by any factor intrinsic in the involved device.
 
Manufacturer Narrative
On (b)(6) 2017 ¿ tte ¿ the study is of very limited quality (poor images and limited views).There is a bioprosthetic aortic valve in place.Mean and peak gradients seem to be unremarkable (8/12 mmhg).Doppler velocity index is normal at 0.5.There is mild aortic regurgitation, cannot determine if central or paravalvular, nor the underlying mechanism.A tee could help describe this better.A complete manufacturing and material records review for the device has been performed.The results confirmed that the device satisfied all material, visual and performance standards required at the time of manufacture and release.
 
Event Description
Information was provide that the guiding sutures were removed and the decalcification was done properly.Looking at the explanted prosthesis, one of the cusps is, due to its abnormal shape, creating an incomplete ¿mercedes sign¿, restricting the haemodynamics.Thus, the surgeon believes this fabrication issue is what causes the central leakage.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
PERCEVAL SUTURELESS AORTIC HEART VALVE
Type of Device
TISSUE HEART VALVE
Manufacturer (Section D)
SORIN GROUP ITALIA S.R.L
strada per crescentino,
saluggia
Manufacturer (Section G)
SORIN GROUP ITALIA
strada per crescentino, sn
saluggia
Manufacturer Contact
francesca crovato
5005 fraser north way
burnaby, bc 
MDR Report Key6386980
MDR Text Key69351838
Report Number3005687633-2017-00014
Device Sequence Number1
Product Code LWR
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
P150011
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Reporter Occupation Physician
Type of Report Initial,Followup,Followup,Followup
Report Date 07/10/2017
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Physician
Device Expiration Date02/16/2019
Device Model NumberPVS23
Device Catalogue NumberICV1209
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer03/09/2017
Is the Reporter a Health Professional? Yes
Initial Date Manufacturer Received 02/06/2017
Initial Date FDA Received03/08/2017
Supplement Dates Manufacturer ReceivedNot provided
Not provided
06/29/2017
Supplement Dates FDA Received04/07/2017
06/22/2017
07/10/2017
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured02/17/2015
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age77 YR
-
-